0.829
IF
20
MNiSW
166.26
ICV
Online first
RESEARCH PAPER
 
CC BY-NC-ND 3.0
 
 

Attitudes of women after the age of 50 towards preventive screening

Anna Pacian 1,  
 
1
Department of Public Health, Faculty of Health Sciences, Medical University of Lublin, Lublin, Poland
2
Department of Physiotherapy, Faculty of Medicine, University of Information Technology and Management, Rzeszow, Poland
3
Student scientific circle at the Department of Public Health, Medical University of Lublin, Lublin, Poland
KEYWORDS:
ABSTRACT:
Introduction:
Prevention is one of the major branches of the health sector. The National Health Programme encompasses main risk factors, elimination of which may lead to a reduced incidence of illnesses in the society. At the same time, the criteria of selecting people eligible for preventive screening are established according to risk groups determined by sex, as well as age in the population of women. The perimenopausal and menopausal period contributes to occurrence of numerous systemic diseases and to an increased risk of illnesses, especially cancers.

Objective:
The objective of the research was to evaluate the performance of preventive screening tests of women after 50 aimed at early detection of cervical and breast cancer. Furthermore, the research estimated frequency of pathological lesions detected and regularity of their monitoring.

Materials and methods:
The research covered 150 women after 50 years of age. The database was statistically examined with STATISTICA software.

Results:
A low percentage of the respondents, in comparison to the risk increasing with age, had a Pap test (61.3%) and mammography (51.3%) in the last two years. In the case of women whose latest Pap test or mammography showed abnormalities and was the basis for diagnosing pathological lesions, 69.2% of them were under regular medical supervision if abnormalities were identified by a Pap test and 68.7% if lesions were detected in breast structure.

Conclusions:
In the examined group we observed a small percentage of women undergo Pap tests and mammography. Furthermore, medical recommendations regarding early detection of cancers are frequently ignored and disregarded by patients.

CORRESPONDING AUTHOR:
Marlena Krawczyk-Suszek   
Department of Physiotherapy, Faculty of Medicine, University of Information Technology and Management, Rzeszow, Poland
 
REFERENCES:
1. Bokiniec M. Menopauza. Przegląd Menopauzalny 2008; 3: 144–147.
2. Driancourt MA. Gouegeon A. Royere D. et al. Ovarian function. In: Reproduction in Mammals and Man. Thiblaut C, Levasseur MC, Hunter RHF [ed.]. Ellipses. Paris 1993, p. 281–305.
3. Utian WH. The true clinical features of postmenopause and oophorectomy and their response to oestrogen therapy. South African Med. J 1972; 46: 732–7.
4. Petryński T. Stachowiak G. Stetkiewicz T. Rola ginekologa w okresie pre- i około menopauzalnym. Przegląd Menopauzalny 2007; 2: 63–69.
5. Pertyński T. Stetkiewicz T. Perimenopauza. In: Diagnostyka i terapia wieku menopauzalnego. Pertyński T [ed.], Urban & Partner, Wrocław 2004, p. 313–22.
6. http://www2.mz.gov.pl/wwwfiles/ma_struktura/docs/zal_urm_npz_90_15052007p.pdf (3 rd march 2014).
7. http://www.nfz.gov.pl/new/index.php?katnr=6&dzialnr=145&artnr=4659 (3 rd march 2014).
8. Słońska Z. Karski B. Promocja zdrowia. Wyd. Sanmedia, Warszawa 1995.
9. Malarewicz A. Rokita W. Effectiveness of routinely repeated prophylactic tests in cervical carcinoma. 10th International Meeting of Gynaecological Oncology. Coimbra, Portugal: Monduzzi Editore 26 April-2 May 1997. 1997, 47–50.
10. Fahey M. Irwig L. Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol. 1995, 141, 680–689.
11. Tabar L. Tot T. Dean P. Rak piersi. Wczesne wykrywanie przy użyciu mammografii. Wyd. MediPage, Warszawa 2010.
12. Surdyka D. Monitorowanie losów pacjentek- wykorzystywanie SIMP. Szkolenie dla realizatorów. Populacyjny Program Wczesnego Wykrywania Raka Piersi. Lublin 29.04.2008.
13. Nowicki A., Stogowska I. Wczesne wyniki badania profilaktycznego wykrywania raka piersi. Ginekol Pol. 2007, 78, s. 464–470.
14. Zasada-Cedro K. Cieślińska-Wilk G. Lubiński J. [et al.]. Badania profilaktyczne sutka poszerzone o wywiad genetyczny. Część I. Badania przesiewowe. Pol Prz Radiol. 1998, 63, 83–87.
15. Ferlay J. International Agency for research on Cancer, WHO. GLOBOCAN 2002: cancer incidence, morality and prevelence worldwide [electronic resource] Lyon: IARCPress, 2004.
16. Wronkowski Z. Chmielarczyk W. Zwierko M. Samobadanie piersi. Służba Zdrowia. 2000, 24/26, p. 2926–2929.
17. Woźniak I. Wiedza o schorzeniach nowotworowych narządów kobiecych i postawy kobiet wobec badań profilaktycznych. Probl Pielęg. 2008, 16, p.136–139.
18. Spaczyński M. i wsp. Women’s social conditions and their participation in Cervical Cancer Population Screening program in Poland. Ginekol Pol. 2009, 80, s. 833–838.
19. Spaczyński M. i wsp. Uczestnictwo kobiet w Populacyjnym Programie Profilaktyki i Wczesnego Wykrywania Raka Szyjki Macicy w latach 2007–2009. Ginekol Pol. 2010, 81, s. 655–663.
20. Nowicki A. Borowa I. Maruszak M. Zachowania zdrowotne kobiet w zakresie zapobiegania, wczesnego wykrywania stanów przedrakowych i raka szyjki macicy. Ginekol Pol. 2008, 79:840–849.
21. Zieliński J. Rokosz M. Rak szyjki macicy – czy można zmniejszyć śmiertelność z powodu tej choroby w Polsce? Współcz Onkol. 2000, 4, 216–217.
22. Klasa-Mazurkiewicz D. Emerich J. Milczek T. Próba wyjaśnienia związku zaawansowania klinicznego raka szyjki macicy z długoletnim niezgłaszaniem się na kontrolne badanie ginekologiczne. Ginekol Pol. 2002, 73, 823–828.
23. Franco E. Schlecht N. Saslow D. The epidemiology of cervical cancer. Cancer J. 2003, 9, 348–359.
24. Knihinicka-Mercik Z. Kazimierczak I. Mess E. [et al.] Styl życia kobiet przed rozpoznaniem raka szyjki macicy. Onkol Pol. 2006, 9, 141–144.
eISSN:1898-2263
ISSN:1232-1966